Deutsche Bank’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Deutsche Bank’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-88,250	Closed	-$223K	–	3722
2023 Q4	$223K	Sell	88,250 -4,700	-5%	-$10.9K	﹤0.01%	2815
2023 Q3	$222K	Buy	92,950 +14,537	+19%	+$32.2K	﹤0.01%	2718
2023 Q2	$181K	Sell	78,413 -41,570	-35%	-$117K	﹤0.01%	2945
2023 Q1	$306K	Buy	119,983 +58,223	+94%	+$167K	﹤0.01%	2783
2022 Q4	$155K	Buy	61,760 +1,001	+2%	+$2.79K	﹤0.01%	3096
2022 Q3	$176K	Sell	60,759 -9,998	-14%	-$42.1K	﹤0.01%	3020
2022 Q2	$320K	Buy	+70,757	New	+$421K	﹤0.01%	2875

Deutsche Bank's SLGC Position: Q1 2024 in Review

Deutsche Bank sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 88,250 shares — an estimated $223K sold.

Deutsche Bank first reported a position in SLGC in Q2 2022 and held it in 7 quarters. The position peaked at $320K in Q2 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Deutsche Bank reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Deutsche Bank sold 88,250 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $223K.
Deutsche Bank first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
Deutsche Bank's SomaLogic, Inc. Class A Common Stock position peaked at $320K in Q2 2022.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Deutsche Bank's 13F filing for Q1 2024, filed 15 May 2024.